Non-Pharmacological Management of Hypertension
- Who will benefit from receipt of this evidence?
One of the most important things to note is that hypertension management has been an issue of concern in different parts across the world. Management of hypertension has been a challenge and this indicates that the receipt of non-pharmacological management of hypertension evidence will play a critical role in ensuring that the problem is solved. In this case, as explained by Kario et al. (2020), health care organizations will benefit from the evidence which has been collected and analyzed in this study. Notably, health care organizations have been working hard to ensure that they find a solution and alternative ways through which they can help patients overcome hypertension pressure without incurring increased medical expenses. Through the receipt of evidence in this study, medical practitioners who work in different health care organizations will be able to offer reliable plans of care to patients who are suffering from hypertension.
It is imperative to note that it will also play a critical role in ensuring that leaders and executives in the health care organizations make informed decisions when it comes to strategic planning. For example, the will focus more on developing different strategies through which hypertension patients will be educated about the management of hypertension without using medications. The amount of funds, which are used to purchase hypertensions medications within health care organizations, will be used in other activities or programs. Secondly, it is also worth noting that the patients who suffer from hypertension will be in a position to manage their condition without incurring many expenses. They will be educated on different diets and foods, which they can take to ensure that their blood pressure remains at normal levels. Again, the medical practitioners will also educate patients about some of the physical exercises that they can carry out to control their blood pressure. This will be beneficial to the patients who suffer from hypertension who groups which are at risk of developing the problem (Kario et al., 2020s).